Non-Hodgkin Lymphoma

Filter By:
07:22
At the iwNHL 2014, Prof John Gribben interviews Prof Randy Gascoyne about the significance of the lymphoma microenvironmen​t in tumour biology and therapy. Understanding the biology of the lymphoma micronenvironme​nt may allow rational therapeutic targeting. Emerging clinical studies in this field are...
by:EMJ | 27 views
02:14
At the iwNHL 2014, Prof John Gribben interviews Prof Randy about the significance of the lymphoma microenvironmen​t in tumour biology and therapy. Improved trial designs, consideration of clinical variables and use of higher resolution approaches are recommended to overcome current research limitatio...
by:EMJ | 36 views
05:53
At the iwNHL 2014, Prof John Gribben interviews Prof Randy about the significance of the lymphoma microenvironmen​t in tumour biology and therapy. It has been increasingly recognised that the interaction between tumour cells and non-tumour cells is essential in disease progression.
by:EMJ | 40 views
12:23
Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma and it can be aggressive. Drs. John Gribben and Wyndham Wilson discuss new research shows promise for many. Get email alerts | http://www.p... Subscribe on YouTube | http://www.y... Like on Facebook | http://ww......
by:patientpower | 75 views
23:18
Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Dr Wyndham Wilson (National Cancer Institute, Bethesda, USA), Prof Anton Hagenbeek (Academic Medical Center, Amsterdam, Netherlands), Prof Michael Pfreundschuh (University of Saarland, Homburg-Saar, Germany) and Dr Myron...
by:EMJ | 113 views
12:07
Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Prof Randy Gascoyne (British Columbia Cancer Agency, Vancouver, Canada), Dr Wyndham Wilson (National Cancer Institute, Bethesda, USA) and Dr Myron Czuczman (Roswell Park Cancer Institute, Buffalo, USA) about the highligh...
by:EMJ | 128 views
14:37
At the iwNHL 2014, Prof Michael Pfreundschuh, Dr Rich Fisher and Prof Christian Gisselbrecht discuss the biology and management of diffuse large B-cell lymphoma (DLBCL). Dr Fisher describes the difficulties in defining and managing patients who are not cured by standard therapy. The classification of DLBCLs is an important consideration for researc...
by:EMJ | 37 views
09:24
At the iwNHL 2014, Prof Eva Kimby and Prof Susan O’Brien provide an overview of their understanding of mantle cell lymphoma. Current treatment strategies are discussed. There is a focus on ibrutinib therapy for patients who relapse after first-line therapy and a comparison is made with its use in treating chronic lymphocytic leukaemia. Future trial...
by:EMJ | 51 views
05:19
Recorded at the 2014 International Workshop on Non-Hodgkin Lymphoma, Dr. Owen O’Connor gives an update on brentuximab vedotin (Adcetris), an antibody drug conjugate (ADC) approved for the treatment of CD30-positive lymphomas, like anaplastic large-cell lymphoma and Hodgkin lymphoma. Dr. O’Connor exp...
by:patientpower | 326 views
07:37
Watch as Dr. Owen O’Connor gives us an overview of the state of treatment for T-Cell lymphoma and the latest news on emerging therapies. Despite a historical challenge in treating T-cell lymphomas, Dr. O’Connor is encouraged by the recent drug approvals and ongoing clinical trials into the use of histone deacetylase (HDAC) inhibitors both as single...
by:patientpower | 351 views
Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)